financetom
Business
financetom
/
Business
/
Heroux-Devtek to be Acquired by U.S.-Based PE Firm Platinum Equity for $1.35 Billion
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Heroux-Devtek to be Acquired by U.S.-Based PE Firm Platinum Equity for $1.35 Billion
Jul 11, 2024 6:20 AM

09:09 AM EDT, 07/11/2024 (MT Newswires) -- Heroux-Devtek ( HERXF ) , an international manufacturer of aerospace products and the world's third-largest landing gear manufacturer, said on Thursday that it has agreed to be bought by an affiliate of U.S private equity firm Platinum Equity Advisors for an enterprise value of about $1.35 billion.

The Platinum affiliate will buy all the outstanding common shares of Heroux-Devtek ( HERXF ), other than the shares to be rolled over by senior management, for $32.50 a piece in cash.

The price is a 28% premium to the closing share price on July 10 and a 47% premium to the 90-day volume weighted average trading price per share on the Toronto Stock Exchange for the period ending on July 10, Heroux-Devtek ( HERXF ) said.

The company's shares closed Wednesday down $0.08 at $25.32 on the TSX.

Members of senior management, including Gilles Labbe, executive chairman of the board, and Martin Brassard, president and chief executive officer, will roll over a portion of their common shares of the company to the purchaser for an amount per share equal to the consideration received by the company's shareholders.

Platinum Equity said Heroux-Devtek ( HERXF ) will maintain and invest in its headquarters and other operations in Quebec.

Heroux-Devtek's ( HERXF ) board has recommended that the shareholders approve the transaction. The deal is expected to close before the end of the company's current fiscal year ending March 31, 2025.

The agreement includes a termination fee of $40 million, which would be paid by Heroux-Devtek ( HERXF ) to the purchaser in certain circumstances, including if the company supports a superior proposal. Heroux-Devtek ( HERXF ) would also be entitled to a reverse termination fee of $63 million if the buyer fails to close the deal under certain circumstances.

After the closing of the deal, the company will become a privately held entity and will apply to cease to be a reporting issuer under Canadian securities laws and the common shares will no longer be publicly traded on the Toronto Stock Exchange.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Mar 22, 2024
(Reuters) - Popular investor Cathie Wood's ARK Invest bought nearly 10,000 shares of Reddit ( RDDT ) in the social media platform's strong market debut on Thursday, an email from the asset manager showed. A total of 9,982 shares of the loss-making company was added to ARK Next Generation Internet ETF ( ARKW ) and ARK Fintech Innovation ETF (...
Japan's union group Rengo announces biggest wage hikes on record
Japan's union group Rengo announces biggest wage hikes on record
Mar 22, 2024
TOKYO (Reuters) -Japanese firms have agreed to raise pay by 5.25% this year, the biggest rise under comparable data since 2013, the country's largest union group Rengo confirmed on Friday. The results of the closely-watched wage negotiations are announced in several stages, in which the blue-chip firms are first to wrap up their talks in mid-March. The second announcement on...
Once a beacon of stability, Vietnam to name third president in a year
Once a beacon of stability, Vietnam to name third president in a year
Mar 22, 2024
HANOI, March 22 (Reuters) - Communist-ruled Vietnam is seeking its third president in little more than a year after the resignation of Vo Van Thuong, who was only elected last year after the sudden dismissal of his predecessor. With accumulated foreign direct investment higher than its gross domestic product, Vietnam's stability is crucial to multinationals with large operations in the...
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Mar 22, 2024
05:04 AM EDT, 03/22/2024 (MT Newswires) -- Hutchmed ( HCM ) said late Thursday it has started the registration stage for a phase 2/3 clinical trial of investigational drug sovleplenib for adult patients with warm antibody autoimmune hemolytic anemia in China. The move follows positive data from the proof-of-concept phase 2 stage of the trial and a consultation with the...
Copyright 2023-2025 - www.financetom.com All Rights Reserved